STATEMENTS OF STOCKHOLDERS' EQUITY/DEFICIT - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest	Total
Stockholders Equity, Beginning balance at Mar. 31, 2017	$ 12,441	$ 43,569,864	$ (35,255,045)	$ 77,421	$ 8,404,681
Shares, Outstanding Beginning balance at Mar. 31, 2017	124,406,818
Issuance of stock for debt conversion, value	$ 1,523	3,804,711			3,806,234
Issuance of stock for debt conversion, shares	15,231,828
Exercise of warrants for stock, value	$ 417	3,783			4,200
Exercise of warrants for stock, shares	4,168,940
Issuance of stock for services, value	$ 192	667,386			667,578
Issuance of stock for services, shares	1,928,845
Share based compensation expense		1,821,294			1,821,294
Issuance of stock for cash, net of issuance costs, value	$ 1,800	7,198,200			7,200,000
Issuance of stock for cash, net of issuance costs, shares	18,000,000
Beneficial conversion feature on notes payable		8,120,988			8,120,988
Contributions from non-controlling interest				3,120,000	3,120,000
Deconsolidation of GB Sciences Puerto Rico, LLC				(129,396)	(129,396)
Stock issued to settle Pacific Leaf royalty agreement, value	$ 160	1,039,840			1,040,000
Stock issued to settle Pacific Leaf royalty agreement, share	1,600,000
Stock issued to employees, value	$ 20	33,466			33,486
Stock issued to employees, shares	195,140
Compensation Warrants, value	$ 309	4,701,572			4,701,881
Compensation Warrants, shares	3,085,284
Net Loss			(22,974,190)		(22,974,190)
Loss attributable to non-controlling interest				(185,035)	(185,035)
Stockholders Equity, Ending balance at Mar. 31, 2018	$ 16,862	70,961,104	(58,229,235)	2,882,990	15,631,721
Shares, Outstanding, Ending Balance at Mar. 31, 2018	168,616,855
Issuance of stock for debt conversion, value	$ 1,856	4,639,115			4,640,971
Issuance of stock for debt conversion, shares	18,563,885
Exercise of warrants for stock, value	$ 1,266	3,919,454			3,920,720
Exercise of warrants for stock, shares	12,657,875
Issuance of stock for services, value	$ 403	1,253,960			1,254,363
Issuance of stock for services, shares	4,032,407
Share based compensation expense		1,966,388			1,966,388
Issuance of stock for cash, net of issuance costs, value	$ 3,616	6,518,509			6,522,125
Issuance of stock for cash, net of issuance costs, shares	36,156,080
Beneficial conversion feature on notes payable		176,471			176,471
Contributions from non-controlling interest				6,999,889	6,999,889
Stock issued to settle Pacific Leaf royalty agreement, value	$ 60	130,940			131,000
Stock issued to settle Pacific Leaf royalty agreement, share	600,000
Compensation Warrants, value		592,638			592,638
Compensation Warrants, shares
Induced Dividend from warrant exercises		2,861,436	(2,861,436)
Net Loss			(23,653,165)		(23,653,165)
Loss attributable to non-controlling interest				(1,027,122)	(1,027,122)
Stockholders Equity, Ending balance at Mar. 31, 2019	$ 24,063	$ 93,020,015	$ (84,743,836)	$ 8,855,757	$ 17,155,999
Shares, Outstanding, Ending Balance at Mar. 31, 2019	240,627,102